ConductScience.org, home

Paper7585151

Neutralization of HIV-1 by secretory IgA induced by oral immunization with a new macromolecular multicomponent peptide vaccine candidate.

Bukawa H and 6 others. Nat Med, 1995. Cited by 101 papers, by iCite.

Cite this record

ConductScience Library. Neutralization of HIV-1 by secretory IgA induced by oral immunization with a new macromolecular multicomponent peptide vaccine candidate. Papers, record 7585151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7585151

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Neutralization of HIV-1 by secretory IgA induced by oral immunization with a new macromolecular multicomponent peptide vaccine candidate.
PubMed
Journal
Nat Med
PubMed
Year
1995
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
101
iCite
Relative citation ratio, by iCite
2.7
iCite
Revised in PubMed
2026-10-09
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bukawa HH
2Sekigawa KK
3Hamajima KK
4Fukushima JJ
5Yamada YY
6Kiyono HH
7Okuda KK

Source PubMed

Download CSV of authors

Topics22

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AIDS VaccinesMajor topic
Cholera ToxinMajor topic
HIV AntibodiesMajor topic
HIV Envelope Protein gp120Major topic
HIV-1Major topic
Immunoglobulin A, SecretoryMajor topic
Peptide FragmentsMajor topic
Vaccines, SyntheticMajor topic
Administration, Oral
Amino Acid Sequence
Animals
Antibody Specificity
Binding Sites
CD4 Antigens
Consensus Sequence
Gastric Mucosa
Intestinal Mucosa
Japan
Mice
Mice, Inbred BALB C
Molecular Sequence Data
Neutralization Tests

Source PubMed

Download CSV of topics

References5

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
13021614Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens.Immunology1986https://conductscience.org/library/papers/3021614PubMed
21370524A chemically defined synthetic vaccine model for HIV-1.J Immunol1992https://conductscience.org/library/papers/1370524PubMed
38107223Mucosal model of genital immunization in male rhesus macaques with a recombinant simian immunodeficiency virus p27 antigen.J Virol1994https://conductscience.org/library/papers/8107223PubMed
48157978Serum IgA-mediated neutralization of HIV type 1.J Immunol1994https://conductscience.org/library/papers/8157978PubMed
58478097Oral immunization with Toxoplasma gondii antigens in association with cholera toxin induces enhanced protective and cell-mediated immunity in C57BL/6 mice.Infect Immun1993https://conductscience.org/library/papers/8478097PubMed

Download CSV of references

Cited by24

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 101 citations.

PMIDTitleJournalYearIn PapersSource
38620211Current situation in the development of a preventive HIV vaccine.Enferm Infecc Microbiol Clin2005https://conductscience.org/library/papers/38620211PubMed
25066739Apoptosis of antigen-specific CTLs contributes to low immune response in gut-associated lymphoid tissue post vaccination.Vaccine2014https://conductscience.org/library/papers/25066739PubMed
23771850Enhanced antitumor efficacy by combination treatment with a human umbilical vein endothelial cell vaccine and a tumor cell lysate-based vaccine.Tumour Biol2013https://conductscience.org/library/papers/23771850PubMed
21441496HIV infection and specific mucosal immunity: workshop 4B.Adv Dent Res2011https://conductscience.org/library/papers/21441496PubMed
19391169Adenovirus type 5 with modified hexons induces robust transgene-specific immune responses in mice with pre-existing immunity against adenovirus type 5.J Gene Med2009https://conductscience.org/library/papers/19391169PubMed
18829757Excretion of human immunodeficiency virus type 1 through polarized epithelium by immunoglobulin A.J Virol2008https://conductscience.org/library/papers/18829757PubMed
18505437Salivary human immunodeficiency virus (HIV)-1-specific immunoglobulin A in HIV-1-exposed infants in Kenya.Clin Exp Immunol2008https://conductscience.org/library/papers/18505437PubMed
16956641Immunoglobulin A antibodies against internal HIV-1 proteins neutralize HIV-1 replication inside epithelial cells.Virology2006https://conductscience.org/library/papers/16956641PubMed
16373000Current situation in the development of a preventive HIV vaccine.Enferm Infecc Microbiol Clin2005https://conductscience.org/library/papers/16373000PubMed
16079886Prime-boost vaccination with plasmid DNA and a chimeric adenovirus type 5 vector with type 35 fiber induces protective immunity against HIV.Gene Ther2005https://conductscience.org/library/papers/16079886PubMed
15254206Induction of mucosal and systemic neutralizing antibodies against human immunodeficiency virus type 1 (HIV-1) by oral immunization with bovine Papillomavirus-HIV-1 gp41 chimeric virus-like particles.J Virol2004https://conductscience.org/library/papers/15254206PubMed
14632739The role of infant immune responses and genetic factors in preventing HIV-1 acquisition and disease progression.Clin Exp Immunol2003https://conductscience.org/library/papers/14632739PubMed
11472406Activation of HIV-1-specific immune responses to an HIV-1 vaccine constructed from a replication-defective adenovirus vector using various combinations of immunization protocols.Clin Exp Immunol2001https://conductscience.org/library/papers/11472406PubMed
11280928Cowpea mosaic virus as a vaccine carrier of heterologous antigens.Mol Biotechnol2001https://conductscience.org/library/papers/11280928PubMed
108000938 Br-cAMP enhances both humoral and cell-mediated immune responses induced by an HIV-1 DNA vaccine.Gene Ther2000https://conductscience.org/library/papers/10800093PubMed
9933462Macrophage inflammatory protein-1alpha (MIP-1alpha) expression plasmid enhances DNA vaccine-induced immune response against HIV-1.Clin Exp Immunol1999https://conductscience.org/library/papers/9933462PubMed
9882293Chimeric plant virus particles administered nasally or orally induce systemic and mucosal immune responses in mice.J Virol1999https://conductscience.org/library/papers/9882293PubMed
9767429Intranasal administration of human immunodeficiency virus type-1 (HIV-1) DNA vaccine with interleukin-2 expression plasmid enhances cell-mediated immunity against HIV-1.Immunology1998https://conductscience.org/library/papers/9767429PubMed
9573261Induction of systemic and mucosal immune responses to human immunodeficiency virus type 1 by a DNA vaccine formulated with QS-21 saponin adjuvant via intramuscular and intranasal routes.J Virol1998https://conductscience.org/library/papers/9573261PubMed
9529888Oral microbial ecology and the role of salivary immunoglobulin A.Microbiol Mol Biol Rev1998https://conductscience.org/library/papers/9529888PubMed

See all 24 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CD79A973PubTator's text mininghttps://conductscience.org/library/genes/973

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7585151

GET https://conductscience.org/api/papers/v1/7585151/cited_by?page=2